myeloproliferative

(redirected from Myeloproliferative disease)
Also found in: Dictionary, Wikipedia.
Related to Myeloproliferative disease: collagen vascular disease, polycythemia vera

myeloproliferative

 [mi″ĕ-lo-pro-lif´er-ah″tiv]
pertaining to or characterized by abnormal proliferation of bone marrow constituents.
myeloproliferative disorders a group of usually neoplastic diseases, which may be related histogenetically by a common multipotential stem cell; it includes among others acute myelogenous leukemia, chronic granulocytic leukemia, acute and chronic myelomonocytic leukemias, and polycythemia vera. An interrelationship with the lymphoproliferative disorders is thought to exist.

my·e·lo·pro·lif·er·a·tive

(mī'ĕ-lō-prō-lif'ĕr-ă-tiv),
Pertaining to or characterized by unusual proliferation of myelopoietic tissue.

myeloproliferative

(mī′ə-lō-prə-lĭf′ə-rā′tĭv, -lĭf′ə-rə-tĭv)
adj.
Relating to excess proliferation of hematopoietic stem cells, chiefly in the bone marrow, as in chronic myelogenous leukemia and polycythemia vera.

myeloproliferative

(mī′ə-lō-prə-lĭf′ə-rā′tĭv, -ər-ə-tĭv)
adj.
Relating to or characterized by the proliferation of cells of the bone marrow: myeloproliferative disorders.

my·e·lo·pro·lif·er·a·tive

(mī'ĕ-lō-prō-lif'ĕr-ă-tiv)
Pertaining to or characterized by unusual proliferation of myelopoietic tissue.
References in periodicals archive ?
Meanwhile patients that were pregnant, infected or inflamed, cirrhosis hepatis or malaria, in the usage of drugs affecting leucocyte count or imatinib level, with other myeloproliferative diseases (PV, TE, MMM) were excluded.
The Flt3-ITD mouse has a myeloproliferative disease with expanded myeloid populations [19].
(2002) FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model.
Most patients with KPC-Kp bloodstream infection had acute myeloid leukemia (14, 53.8%); others had non-Hodgkin lymphoma (4, 15.4%), acute lymphoid leukemia (3, 11.6%), Hodgkin lymphoma (2, 7.8%), myeloproliferative disease (1, 3.8%), myelodysplastic syndrome (1, 3.8%), or aplastic anemia (1, 3.8%).
(7) Patients with both chronic myeloid leukemia (or a myeloproliferative disorder) and myeloid sarcoma have worse prognoses relative to those with only chronic myeloid leukemia (or myeloproliferative disease) because myeloid sarcoma discovery often antedates acute or blast transformation.
A number of conditions have been associated with Wells syndrome like arthropod bites, myeloproliferative disease, colon cancer, Churg-Strauss syndrome, dental abscess, herpes simplex infection, onchocerciasis, drug reactions etc.1,2,3 Peripheral blood eosinophilia is observed in approximately 50% of the patients.
Polycythemia vera (PV) is a myeloproliferative disease characterized by increased production of RBC of the bone marrow.
(2) However, in patients with underlying myeloproliferative disease and adequate treatment of BCS, the increased risk of developing neoplastic diseases poses a great risk for their long term survival.
After 6 to 12 months of transplantation, the expansion led to the development of a myeloproliferative disease, which can evolve to leukaemia.
Essential thrombocytemia (ET) is a rare myeloproliferative disease characterized by a persistent increase in platelet numbers and platelet dysfunction.
Extramedullary hematopoiesis has been reported in patients with myeloproliferative disease. In fact, splenomegaly seen with this disorder is generally the result of extramedullary hematopoiesis in the spleen.